Literature DB >> 24019301

SOX12 and NRSN2 are candidate genes for 20p13 subtelomeric deletions associated with developmental delay.

Yu An1, Sami S Amr, Alcy Torres, Laura Weissman, Peter Raffalli, Gerald Cox, Xiaoming Sheng, Va Lip, Weimin Bi, Ankita Patel, Pawel Stankiewicz, Bai-Lin Wu, Yiping Shen.   

Abstract

20p13 telomeric/subtelomeric deletions are clinically significant but are currently under-investigated. So far only five molecularly delineated cases have been reported in literature and no candidate genes have been sufficiently implicated. Here, we present six new deletion cases identified by chromosomal microarray analysis (CMA). We also review 32 cases combined from literature and databases. We found that most 20p13 deletion patients exhibit significant developmental delay. Dysmorphic features are common but a consistent pattern was not recognized. Reduced cognitive ability was frequent. Based on pathogenic deletions delineated in this study, we mapped the smallest overlapping region and identified two nervous system expressing genes (SOX12 and NRSN2) as candidate genes that may be involved in the developmental defects in 20p13 microdeletion.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  20p13; NRSN2; SOX12; developmental delay; microdeletion

Mesh:

Substances:

Year:  2013        PMID: 24019301     DOI: 10.1002/ajmg.b.32187

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  8 in total

1.  NRSN2 promotes non-small cell lung cancer cell growth through PI3K/Akt/mTOR pathway.

Authors:  Xin-Yi Zhang; Jiu-Long Kuang; Chun-Song Yan; Xiao-Yun Tu; Ji-Hua Zhao; Xiao-Shu Cheng; Xiao-Qun Ye
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Down-Regulated NRSN2 Promotes Cell Proliferation and Survival Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma.

Authors:  Xin Wang; Longzhi Han; Jianjun Zhang; Qiang Xia
Journal:  Dig Dis Sci       Date:  2015-06-09       Impact factor: 3.199

3.  Diagnostic efficacy and new variants in isolated and complex autism spectrum disorder using molecular karyotyping.

Authors:  Luca Lovrečić; Polona Rajar; Marija Volk; Sara Bertok; Barbara Gnidovec Stražišar; Damjan Osredkar; Maja Jekovec Vrhovšek; Borut Peterlin
Journal:  J Appl Genet       Date:  2018-03-21       Impact factor: 3.240

4.  Separating the wheat from the chaff: systematic identification of functionally relevant noncoding variants in ADHD.

Authors:  J H S Tong; Z Hawi; C Dark; T D R Cummins; B P Johnson; D P Newman; R Lau; A Vance; H S Heussler; N Matthews; M A Bellgrove; K C Pang
Journal:  Mol Psychiatry       Date:  2016-04-26       Impact factor: 15.992

Review 5.  Phenotypic features of a microdeletion in chromosome band 20p13: A case report and review of the literature.

Authors:  Hung-Hsiang Fang; Shih-Yao Liu; Ying-Fu Wang; Che-Ming Chiang; Chiung-Chen Liu; Chien-Ming Lin
Journal:  Mol Genet Genomic Med       Date:  2019-05-13       Impact factor: 2.183

6.  Clinical and molecular cytogenetic analyses of four patients with imbalanced translocations.

Authors:  Hong Yan Liu; Jia Huang; Tao Li; Dong Wu; Hong Dan Wang; Yue Wang; Tao Wang; Liang Jie Guo; Qian Nan Guo; Fei Fei Huang; Rui Li Wang; Ying Tai Wang
Journal:  Mol Cytogenet       Date:  2016-04-19       Impact factor: 2.009

7.  Deletion of 20p13 and Duplication of 20p13p12.3 in a Patient with Delayed Speech and Development.

Authors:  Soon Sung Kwon; Jieun Kim; Saeam Shin; Seung Tae Lee; Kyung A Lee; Jong Rak Choi
Journal:  Ann Lab Med       Date:  2018-01       Impact factor: 3.464

8.  NRSN2 promotes breast cancer metastasis by activating PI3K/AKT/mTOR and NF-κB signaling pathways.

Authors:  Fei Ren; Wei Zhang; Shuai Lu; Hong Ren; Yantong Guo
Journal:  Oncol Lett       Date:  2019-11-28       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.